MaSTherCell is a dynamic and global Contract Development and Manufacturing Organization (CDMO) on a mission to deliver optimized process industrialization capacities to cell therapy organizations, and speed up the arrival of their therapies onto the market. The heart of MaSTherCell is a team of 80 highly dedicated experts combining strong experience in cGMP cell therapy manufacturing with a technology-focused approach and a substantial knowledge of the industry.
From technology selection to business modeling, process development, quality management and assay development, MaSTherCell’s teams are fully committed to helping their clients fulfill their objective of providing sustainable and affordable therapies to their patients. Our company releases cell therapy lots from phase I to phase III for worldwide customers.
The company operates in a validated and flexible facility located in the strategic center of Europe within the Belgian cell therapy cluster. Thanks to our growth, we will double our production capacities by Q1 2017. Worldwide renowned, the center hosts key players from the bio industry and offers a central, highly connected location. Find out more on www.masthercell.com